首页> 外文期刊>Journal of Biomolecular Structure and Dynamics >Exploring the cause of the inhibitor 4AX attaching to binding site disrupting protein tyrosine phosphatase 4A1 trimerization by molecular dynamic simulation
【24h】

Exploring the cause of the inhibitor 4AX attaching to binding site disrupting protein tyrosine phosphatase 4A1 trimerization by molecular dynamic simulation

机译:通过分子动态模拟探讨抑制剂4ax抑制剂4AX的原因破坏蛋白酪氨酸磷酸酶4A1三聚化

获取原文
获取原文并翻译 | 示例
           

摘要

Ectopic overexpression of protein tyrosine phosphatase of liver regeneration-1 (PTP4A1, also called PRL-1) markedly enhanced hepatocellular carcinoma (HCC) cells migration and invasion. The PTP4A1 trimerization played a vital role in mediating cell proliferation and motility. Biochemical and structural studies have proved that the compound 4AX, a well-known inhibitor for PRL1, directly binds to the PTP4A1 trimer interface and obstructs trimer formation of PTP4A1. However, the molecular basis of the ligand-4AX inhibition on PTP4A1 trimer conformations remains unclear. In this study, the docking analysis and the molecular dynamics simulation (MD simulation) study were performed to investigate how the molecule binding at each interface disrupted the trimer formation. The results suggested that the ligand-4AX attaching to the binding site changed the conformation of A:Q131, A:Q135 in the AC interface, C:R18, C:P96 in the CA interface and B:Q131 in the BA interface, leading to the weak interactions between subunits and thus resulting in the disruption of the PTP4A1 trimerization.
机译:肝再生-1(PTP4A1,也称为PRL-1)的蛋白质酪氨酸磷酸酶的异位过表达显着增强了肝细胞癌(HCC)细胞迁移和侵袭。 PTP4A1三聚化在介导细胞增殖和运动方面发挥了至关重要的作用。已经证明了生物化学和结构研究证明,化合物4ax是PRL1的公知抑制剂直接与PTP4A1三聚物界面结合并阻碍PTP4A1的三聚体形成。然而,在PTP4A1三聚体符合上对配体-4AX抑制的分子基础仍不清楚。在该研究中,进行对接分析和分子动力学模拟(MD模拟)研究以研究在每个界面的分子结合如何破坏三聚体形成。结果表明,附着于结合位点的配体-4ax改变了AC接口中的A:Q131,A:Q135的构象,C:R18,C:P96,BA接口中的B:Q131,引导亚基之间的弱相互作用,从而导致PTP4A1三聚化的破坏。

著录项

  • 来源
  • 作者单位

    Tianjin Med Univ Sch Pharm Tianjin Key Lab Technol Enabling Dev Clin Therape Tianjin Peoples R;

    Chinese Acad Med Sci Inst Radiat Med Tianjin Key Lab Radiat Med &

    Mol Nucl Med Tianjin Peoples;

    Tianjin Med Univ Sch Pharm Tianjin Key Lab Technol Enabling Dev Clin Therape Tianjin Peoples R;

    North China Pharmaceut Grp Corp New Drug Res &

    Dev Ctr Hebei Ind Microbial Metab Engn &

    Technol;

    Tianjin Med Univ Sch Pharm Tianjin Key Lab Technol Enabling Dev Clin Therape Tianjin Peoples R;

    Tianjin Med Univ Sch Pharm Tianjin Key Lab Technol Enabling Dev Clin Therape Tianjin Peoples R;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子生物学;
  • 关键词

    HCC; molecular docking; MD simulation; post-dynamic analysis;

    机译:HCC;分子对接;MD模拟;动态分析;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号